Skip to main content

Table 1 STHLM3 model for prostate cancer screening

From: Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management

STHLM3 model [39]

Blood proteins

PSA, fPSA, intact PSA, hK2, MSMB, MC1

Genetic polymorphisms

232 SNPs

Clinical variables

Age, family history, previous prostate biopsy, prostate exam

Back to article page

Clinical Proteomics

ISSN: 1559-0275